LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 100 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,311 | -50.9% | 42,487 | +3.2% | 0.00% | – |
| Q2 2023 | $94,275 | +7.9% | 41,168 | +14.5% | 0.00% | – |
| Q1 2023 | $87,341 | +27.2% | 35,943 | 0.0% | 0.00% | – |
| Q4 2022 | $68,651 | +80.2% | 35,943 | +126.4% | 0.00% | – |
| Q3 2022 | $38,107 | -45.9% | 15,878 | -52.9% | 0.00% | – |
| Q1 2022 | $70,494 | -54.5% | 33,729 | -14.3% | 0.00% | – |
| Q4 2021 | $155,000 | -17.6% | 39,340 | +0.7% | 0.00% | – |
| Q3 2021 | $188,000 | -1.6% | 39,070 | -5.9% | 0.00% | – |
| Q2 2021 | $191,000 | +3.8% | 41,525 | +32.4% | 0.00% | – |
| Q1 2021 | $184,000 | +68.8% | 31,374 | -1.5% | 0.00% | – |
| Q4 2020 | $109,000 | +78.7% | 31,843 | +1.9% | 0.00% | – |
| Q1 2020 | $61,000 | -49.2% | 31,248 | +8.3% | 0.00% | – |
| Q4 2019 | $120,000 | +14.3% | 28,852 | -5.2% | 0.00% | – |
| Q3 2019 | $105,000 | -44.4% | 30,449 | +1.1% | 0.00% | – |
| Q2 2019 | $189,000 | +5.6% | 30,103 | -6.4% | 0.00% | – |
| Q1 2019 | $179,000 | -6.8% | 32,150 | +11.0% | 0.00% | – |
| Q4 2018 | $192,000 | -44.0% | 28,959 | -9.9% | 0.00% | – |
| Q3 2018 | $343,000 | -20.2% | 32,124 | -10.3% | 0.00% | – |
| Q2 2018 | $430,000 | +38.7% | 35,810 | -1.0% | 0.00% | – |
| Q1 2018 | $310,000 | -12.9% | 36,183 | +0.3% | 0.00% | – |
| Q4 2017 | $356,000 | -18.3% | 36,059 | +1.9% | 0.00% | -100.0% |
| Q3 2017 | $436,000 | -27.2% | 35,397 | -2.8% | 0.00% | 0.0% |
| Q2 2017 | $599,000 | +18.6% | 36,417 | +3.7% | 0.00% | 0.0% |
| Q1 2017 | $505,000 | +16.1% | 35,126 | +11.8% | 0.00% | 0.0% |
| Q4 2016 | $435,000 | -23.0% | 31,414 | +0.5% | 0.00% | 0.0% |
| Q3 2016 | $565,000 | +23.4% | 31,268 | -2.1% | 0.00% | 0.0% |
| Q2 2016 | $458,000 | +24.5% | 31,927 | +6.6% | 0.00% | – |
| Q1 2016 | $368,000 | -9.6% | 29,957 | -2.0% | 0.00% | – |
| Q4 2015 | $407,000 | +23.7% | 30,553 | 0.0% | 0.00% | – |
| Q3 2015 | $329,000 | +33.2% | 30,553 | -0.3% | 0.00% | – |
| Q2 2015 | $247,000 | – | 30,641 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |